ArticleAACE endocrinology and diabetes

Combined Glucagon-like Peptide-1 Receptor Agonist and Sodium-Glucose Cotransporter-2 Inhibitor Use and Survival.

Scott Reule et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.